Data Supplement from SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

Open Access

Publisher Website

31 March 2023

other
Published by American Association for Cancer Research (AACR)

https://doi.org/10.1158/1078-0432.22454570.v1

Abstract

Supplementary Figure S4. Overlay of CD38-SAR650984-Fab and CD38-HB7

Keywords